Selected:

HFSA 2017 Comprehensive Heart Failure Review Course & Update

$20

HFSA 2017 Comprehensive Heart Failure Review Course & Update

$20

– Format: 58 Video Files (.mp4 format).
– File Size: 2.95 GB.
– Additional notes: full product, no more video updates.
– Form: get google drive link and access via gmail.
– Download Link Below.

 

Add to Wishlist
Add to Wishlist

Description

+ Product Details:

– Price: $ 20
– Format: 58 Video Files (.mp4 format).
– File Size: 2.95 GB.
– Additional notes: full product, no more video updates.
– Form: get google drive link and access via gmail.
– Download Link Below.

+ Download Link:

This post contains protected content. You must see payment guide to get the link or contact me.

+ Description: 

2017 Comprehensive Heart Failure Review Course & Update:

The Practical Management of Heart Failure

October 12-15, 2017 | Scottsdale, AZ

The 2017 Comprehensive Heart Failure Review Course builds upon HFSA’s successful 2015 Review and 2016 Board Review Courses  by incorporating results of new research studies, increasing focus on practical management recommendations, addressing issues encountered in practice, adding case studies, and providing breakout session in areas of special interest.

For Attendees Only: Login using your registered email address to access the  full version of the
2017 Review Course Attendee Site.

TARGET AUDIENCE
Cardiologists, internists, nurses, clinical pharmacists and other health professionals with a special interest in heart failure.
EDUCATIONAL FORMAT
Evidence-based presentations including guideline-based practice recommendations. Breakout sessions and case study sessions focusing on practical management issues.
LEARNING OBJECTIVES & COMPETENCIES ADDRESS

Learning Objectives:
At the conclusion of this educational activity, participants will be able to:

  1. Describe the epidemiology of heart failure and implement strategies for the prevention of heart failure.
  2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
  3. Assess and track the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents and nonpharmacologic options, such as diet and exercise; and implantable devices.
  5. Apply appropriate care strategies for patients with pulmonary hypertension, RV failure, heart failure with preserved ejection fraction, cardiorenal syndrome, peripartum and infiltrative myopathies.
  6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression.
  7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care.
  8. Describe characteristics of optimal candidates for cardiac transplantation or mechanical circulatory support.
  9. Apply strategies for atrial and ventricular arrhythmia management.
  10. Practice effectively in the context of health care reform and merit-based incentives.

Competencies Addressed:

ABMS core competencies:

  • Patient care
  • Medical knowledge
  • Interpersonal and communication skills
  • Professionalism
  • Systems‐based

ABIM‐specified competency areas in advanced heart failure and transplant cardiology:

  • Epidemiology and risk factors
  • Pathophysiology of heart failure
  • Hemodynamics and hemodynamic monitoring
  • Heart failure and normal ejection fraction
  • Heart failure with renal dysfunction/cardiorenal syndrome
  • Diagnostic tests and procedures
  • Acute decompensation of chronic heart failure
  • Heart failure comorbidities
  • Cardiomyopathies
  • Pharmacotherapy
  • Implantable devices
  • Heart transplant
  • Mechanical circulatory
CONTINUING EDUCATION CONTENT
 Physician:The Heart Failure Society of America designates this
live activity for a maximum of 19.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.50 MOC points in the Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.Nurses:
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 19.50 contact hours.
Approval valid through 10/05/2019; ONA #21191

 

 

Pharmacists:

The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).
This program provides up to 19.50 contact hours of continuing pharmacy education credit. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program.

Friday, October 13, 2017
UAN: 0046-9999-17-298-L01-P (7.67 contact hours)

Saturday, October 14, 2017
UAN: 0046-9999-17-299-L01-P (8.0 contact hours)

Sunday, October 15, 2017
UAN: 0046-9999-17-300-L01-P (3.83 contact hours)

Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

**No partial credit will be available. You must attend full day of sessions to receive credit**

Topics/Speaker:

B1-1 – Assessment of Patient with New Onset HF
B1-2 – Practical Application of Risk Prediction Models
B1-3 – Sleep Disordered Breathing
B2-1 – Tricks of the Trade Challenges of RAAS Inhibition
B2-2 – Advanced Hemodynamic Modeling
B3-1 – How to Set Up a HF Clinic and Diastolic HF Program
B3-2 – How to Setup a Remote Monitoring Program
B4-1 – Having the Discussion ‐ How to Make the Conversation Easier
B4-2 – Practical Use of Biomarkers in the Clinical Setting
B4-3 – Transplant VAD Case Review
S1-1 – Models and Mechanisms of HFrEF and HFpEF
S1-2 – New Guidelines Update
S1-3 – ARNI’s and Ivabradine
S1-4 – Emerging Therapies for Chronic HF
S1-5 – HFpEF Natural History and Contemporary Management
S1-6 – Case Based Discussion
S2-1 – Natural History & Patient Assessment
S2-2 – Vasodilators & Inotropes What’s New and What Works
S2-3 – Acute HF Congestion, Cardiorenal Syndrome and Diuretic Resistance
S2-4 – Diuretics in Hospitalized patients Current Controversies and Emerging Therapies
S2-5 – Case Based Discussion
S3-1 – Patient Assessment and Classification
S3-2 – Treating PAH in the Contemporary Era
S3-3 – Pulmonary Hypertension and Left HF
S3-4 – Right HF
S3-5 – Case Based Discussion
S4-1 – Biomarker 2017 Update What’s Hot, What’s Not
S4-2 – Invasive and Non‐Invasive Hemodynamic Devices
S4-3 – Remote Monitoring Smart Phones to Telehealth
S5-1 – Clinical Variability within INTERMACS Profile I
S5-2 – Hemodynamics of Cardiogenic Shock and Devices
S5-3 – Percutaneous Devices and ECMO
S5-4 – Q&A
S6-1 – Defining Advanced HF
S6-2 – Heart Transplant Patient Selection
S6-3 – Heart Transplant ‐ Clinical Outcomes and Management
S6-4 – LVAD Patient Selection and Clinical Outcomes
S6-5 – LVAD Adverse Events and Patient Management
S6-6 – Managing Drug Interactions
S6-7 – Q&A
S7-2 – Cardiac Resynchronization Therapy ‐ Recent Advances
S7-3 – Arrhythmia Management Antiarrhythmic Drugs and VT Ablation
S7-4 – Impact of AFIB on HF
S7-5 – Systemic Anticoagulation from VKA to NOAC
S7-6 – Prevention of Sudden Cardiac Death , Wearables and Implantables
S7-7 – Q&A
S8-1 – Reducing 30‐Day Readmissions
S8-2 – Transitioning Patients Out of the Hospital
S8-3 – Strategies for Keeping Patients out of the Hospital
S8-4 – They Are Not Ready for Palliative Care Really Then When
S8-5 – Case Based Discussion
S9-1 – Hypertrophic Cardiomyopathies and Screening for Sudden Cardiac Death
S9-2 – Cardiac Amyloidosis
S9-3 – Pregnancy and Peripartum Cardiomyopathy
S9-4 – Inflammatory Cardiomyopathies & Myocarditis
S9-5 – Metabolic Challenges Obesity, Diabetes, Anemia
S9-6 – Fireside Chat with Patient
S9-7 – Q&A

 

 

 

Reviews

There are no reviews yet.

Be the first to review “HFSA 2017 Comprehensive Heart Failure Review Course & Update”

Your email address will not be published. Required fields are marked *

Close Menu
WhatsApp chat
×
×

Cart